3) Yarden Y, Sliwkowski MX : Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2 : 127-137, 2001
4) Hirsch FR, Scagliotti GV, Langer CJ, et al :Epidermal growth factor family of receptors in preneoplasia and lung cancer ; perspectives for targeted therapies. Lung Cancer 41 : S29-S42, 2003
5) Wakeling AE, Guy SP, Woodburn JR, et al : ZD1839 (Iressa) ; an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy. Cancer Res 62 : 5749-5754, 2002